Welcome

You've successfully logged in

This website uses cookies to provide you with a more responsive and personalized service. In order to proceed to login, however, you must formally accept our cookie policy. Please read our cookie & privacy policies for more information.

Roche Oncology Life Science Research Kits

Our answers. Your insights.

The Roche Oncology Life Science Research (LSR)* kits put our research to work in your lab. These kits comprehensively deliver what you need to make your next discovery – starting with more information. The tests come with access to a real-time data analysis portal for automated, objective interpretation of results, while still giving you the raw data that can help in developing important insights. All this, plus the unparalleled Roche support you can count on.

It’s more than a new LSR portfolio. It’s the answer you’ve been looking for.

The video introduces the Roche Diagnostics’ Oncology Life Science Research Kits and explains the workflow of the LSR assays – starting with the BRAF/NRAS Mutation Test (LSR). It reviews the test features and attributes, highlights the rapid turnaround time, and walks through the simple results reporting step-by-step.

Helpful Links

Roche Oncology Life Science Research Kits FAQ

Roche Oncology LSRs are complete testing kits that are designed to fuel your research. With comprehensive coverage of oncology mutations and a web application to analyze your data, the Oncology LSRs provide the information you need to garner real insights for oncology research.

No. When you use the Web Portal, results are delivered direct to you. Roche does not store, view, or use your data.

Interpreted data is available for 24 hours. After this period, data will need to be re-uploaded for reinterpretation.

Once you upload the raw data into the online Data Analysis tool, the results are delivered to you within a few minutes.

Turn on the cobas z 480 analyzer if it is turned off. If necessary, reboot the cobas® 4800 workstation and log into the User defined Workflow (UDF) partition on the system. Once the system has booted up, follow the appropriate assay Instructions for Use for more information on the Run Setup.

Roche recommends the cobas® DNA Sample Preparation Kit for FFPET samples and the cobas® cfDNA Sample Preparation Kit  for plasma samples however, they are not required.  Please see the appropriate assay Instructions for Use for more detailed information regarding DNA preparation.

The Roche Oncology LSRs come with the same quality of support you get with other Roche assays. For specific questions and concerns, please contact the Roche Support Network Customer Support Center at 1-800-526-1247.

The Data Analysis tool is best viewed in Google Chrome 3 or above, Mozilla Firefox 3.5 or above, and Microsoft Internet Explorer 7 or above.

*FOR LIFE SCIENCE RESEARCH ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.


Data Analysis

 

The LSR* Data Analysis tool is a service that gives researchers access to Roche Diagnostics' unique testing algorithms to automatically interpret data generated by the Oncology LSR test kits. Rather than having to analyze all of the individual data points manually, researchers can have data files analyzed and results generated in .pdf and .csv documents within minutes.

 

You need to be logged in before you can access this feature. Please login here

Helpful Links

 

*FOR LIFE SCIENCE RESEARCH ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

BRAF/NRAS Mutation Test (LSR)

The BRAF/NRAS Mutation Test (LSR)* from Roche is an allele-specific, real-time PCR test for the qualitative detection and identification of exon 11 and 15 mutations in the proto-oncogene B-Raf (BRAF) gene and exon 2, 3, and 4 mutations in the neuroblastoma RAS viral oncogene homolog (NRAS) gene from formalin-fixed, paraffin-embedded tissue (FFPET) or plasma samples.

BRAF/NRAS Mutation Test (LSR)

One test kit for use with FFPET and plasma samples.

Key Features and Benefits

What are Roche Oncology Life Science Research (LSR) kits?

Possibility of broad detection of BRAF and NRAS mutations within an 8-hour laboratory shift

  • Broad detection of 11 BRAF and 25 NRAS mutations within an 8-hour laboratory shift
  • Validated in FFPET samples and can detect BRAF mutations and NRAS mutations at a percent mutation of 5% from a single 5μm section
  • Validated in plasma samples with sensitivity of 100 copies/mL in a wild-type background of 160,000 copies from only 2mL of plasma
  • Can be paired with the KRAS Mutation Test v2 (LSR)* for broad detection of 64 unique RAS/BRAF variants in a single PCR run
  • A web-based analysis tool enables automated, objective, and rapid interpretation of results

BRAF/NRAS LSR TESTING WORKFLOW

When you’re on the path to discovery, every result matters. Every answer could be the one that gets you there. To the revelation you were searching for. To the advancement you needed. To your next breakthrough.

The Roche Life Science Research Oncology Portfolio offers the speed, accuracy, and open-source flexibility your research demands. So you get clear, actionable results faster, in fewer shifts, and backed by the exacting standards, quality, and service of Roche.

***Roche does NOT maintain or store uploaded data and no sample identifying information is collected. Files are only downloadable for a limited time.

 

COVERAGE OF THE BRAF/NRAS MUTATION TEST (LSR):
NRAS COSMIC v.80   SKIN COLON
Freq of Reports LSR* Coverage Freq of Reports LSR* Coverage
exon 2 13.0% 11.8% 42.9% 42.4%
exon 3 86.6% 84.4% 55.8% 54.7%
exon 4 <1%
<1% <1% <1%
TOTAL 99.5% 96.3% 98.7% 97.1%
BRAF COSMIC v.80   SKIN COLON
Freq of Reports LSR* Coverage Freq of Reports LSR* Coverage
exon 11 <1% <1% <1% <1%
exon 15 98.7% 96.3% 99.4% 98.4%
TOTAL 99.0% 96.5% 99.6% 98.5%

† Catalogue of Somatic Mutations in Cancer (COSMIC)

PRODUCT DESCRIPTION QUANTITY MATERIAL NUMBER
BRAF/NRAS Mutation Test (LSR)* 24 07659962001
cobas® 4800 UDF v2.0.0 CD 1 07540922001
cobas® 4800 Microwell Plate and Sealing Foil 50 05232724001

*FOR LIFE SCIENCE RESEARCH ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

FOR MORE INFORMATION

Contact your local Roche Molecular Diagnostic representative or visit molecular.roche.com

For printable BRAF/NRAS Mutation Test (LSR) brochure, click here.

KRAS Mutation Test v2 (LSR)

The KRAS Mutation Test v2 (LSR)* from Roche is an allele-specific, real-time PCR test for the qualitative detection and identification of exon 2, 3, and 4 mutations in the v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) gene from formalin-fixed, paraffin-embedded tissue (FFPET) or plasma samples.

KRAS Mutation Test v2 (LSR)

An allele-specific, real-time PCR test for the detection of 28 unique KRAS mutations in codons 12, 13, 59, 61, 117, and 146

Key Features and Benefits

What are Roche Oncology Life Science Research (LSR) kits?

Possibility of broad detection BRAF of KRAS mutations within an 8-hour laboratory shift

  • Broad coverage of 28 KRAS mutations within an 8-hour laboratory shift
  • Validated in FFPET samples and can reliably detect KRAS variants at ≥1 % mutation from a single, 5μm section.
  • Validated in plasma samples with sensitivity of 75 copies /mL or lower in a wild-type background of 64 ,000 copies from just 2mL of plasma.
  • Can be paired with the BRAF/NRAS Mutation Test (LSR)* for broad detection of 64 unique RAS/BRAF variants in a single PCR run
  • A web-based analysis tool enables automated, objective, and rapid interpretation of result
KRASv2LSR Testing Workflow

KRAS v2 LSR* TESTING WORKFLOW

When you’re on the path to discovery, every result matters. Every answer could be the one that gets you there. To the revelation you were searching for. To the advancement you needed. To your next breakthrough. The Roche Life Science Research Oncology Portfolio offers the speed, accuracy, and open-source flexibility your research demands. So you get clear, actionable results faster, in fewer shifts, and backed by the exacting standards, quality, and service of Roche.

***Roche does NOT maintain or store uploaded data and no sample identifying information is collected. Files are only downloadable for a limited time

 

COVERAGE OF THE KRAS MUTATION TEST v2 (LSR)*:
KRAS COSMIC v.81   COLON LUNG PANCREAS
Freq of Reports LSR* Coverage Freq of Reports LSR* Coverage Freq of Reports LSR* Coverage
exon 2 98.3% 97.7% 98.7% 97.7% 98.8% 98.3%
exon 3 1.0% 0.9% 1.2% 1.1% 1.1% 1.0%
exon 4 0.7% 0.5% 0.06% 0.04% 0.08% 0.04%
all others** 0.01% 0.0% 0.04% 0.0% 0.0% 0.0%
TOTAL 100.0% 99.1% 100.0% 98.8% 100.0% 99.3%

numbers are rounded to the nearest decimal point
† Catalog of Somatic Mutations in Cancer
** mutations outside exon 2, 3 and 4.

PRODUCT DESCRIPTION QUANTITY MATERIAL NUMBER
KRAS Mutation Test v2 (LSR)* 24 07989270001
cobas® 4800 UDF v2.0.0 CD 1 07540922001
cobas® 4800 Microwell Plate and Sealing Foil 50 05232724001

*FOR LIFE SCIENCE RESEARCH ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

FOR MORE INFORMATION

Contact your local Roche Molecular Diagnostic representative or visit molecular.roche.com

For printable KRAS Mutation Test v2 (LSR) brochure, click here

© 2018 Roche Diagnostics, North America 2018-16-03 > Legal and Privacy Statement  
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.